Center for Translational Medicine in Women's Health

Purpose for the Center

The Center for Translational Medicine in Women’s Health supports the development of a comprehensive research effort to assess the molecular origin of diseases affecting women, with an initial emphasis on cancer. The overall goals of the program are to define the molecular basis and genetic alterations that result in the initiation of disease and to develop diagnostic, preventative, and treatment strategies to combat illnesses that significantly impact women’s health.

Activities

The program also supports the Tumor Vaccine Group, which is a multidisciplinary group of investigators focused on the diagnosis, prevention, and treatment of cancer with novel, immune-based therapies. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care. Cancer immunology is an extremely new and exciting field. Scientists and research physicians are constantly gaining greater understanding about the way the immune system interacts with cancer. They are discovering and developing new, immune-based treatments that are now becoming standard of care in addition to surgery, chemotherapy, and radiation. These treatments impact everyone who is affected by cancer – from families and organizations in the local community to researchers and patients throughout the world. We invite you to explore the work that we are doing, through scientific research and clinical trials, to further cancer’s diagnosis, treatment, and prevention.  Please visit us at www.tumorvaccinegroup.org.